3 Predictions for the New Week

I went out on a limb last week, and now it's time to see how that decision played out.

  • I predicted that RadioShack (NYSE: RSH  ) would post a wider loss than expected. The struggling small-box retailer of wireless products and other consumer electronics was having a hard time keeping its red ink in check in recent quarters, and larger chains had already provided uninspiring snapshots of the niche. Well, the report was brutal. RadioShack's adjusted loss of $1.29 a share was far worse than the $0.13 analysts were forecasting. I was right.
  • The Dow Jones Industrial Average (DJINDICES: ^DJI  ) has been strong lately, but my second prediction still called for the tech-heavy Nasdaq Composite to outpace the Dow. It was close, but the Dow's 0.8% advance squeaked past Nasdaq's 0.7% gain. I was wrong.
  • My final call was for Ambarella (NASDAQ: AMBA  ) to beat Wall Street's income estimates in its latest quarter. The provider of system-on-chip solutions for the HD camera industry has been riding high with its handiwork found in GoPro sports enthusiasts' cameras and Dropcam home security products. Ambarella closed out the quarter with an adjusted profit of $0.26 a share. Analysts had been banking on net income of $0.19. I was right.

Two out of three? I can live with that! I have now gone a solid 20 out of 24 over the past eight weeks.

Let me once again whip out my trusty, dusty, and occasionally accurate crystal ball to make three calls that may play out over the next few trading days.

1. Novavax will post a wider loss than expected
Novavax (NASDAQ: NVAX  ) is a widely traded maker of vaccines. It moved higher late last month after extending its contract with the U.S. Department of Health and Human Sciences to develop seasonal and pandemic influenza vaccines.

Unfortunately, Novavax is losing money, and analysts seem to underestimate the red ink. Wall Street has failed to nail its projections when it comes to Novavax, aiming for a much smaller deficit than what the vaccine maker ultimately reports.

Why get in the way of a long-running streak? My first call is for Novavax to post a wider quarterly loss than Wall Street's projecting this week.

2. The Nasdaq will beat the Dow this week
I've routinely picked the tech-heavy Nasdaq Composite to beat the Dow Jones Industrial Average, but I've been switching things out in recent weeks. I'm going back to my original call this time around, betting on a strong week for tech now that earnings season is starting to wind down. This approach didn't pan out for me this past week, but that won't deter me.

My second call is for the Nasdaq Composite to outperform the Dow Jones Industrial Average on the week.

3. magicJack VocalTec will beat Wall Street's earnings estimates
Some stocks are just flat-out better than others.

magicJack VocalTec (NASDAQ: CALL  ) is a provider of Web-based phone services. Consumers looking to save money have been ditching traditional landlines, and the VoIP pioneer has sold 10 million of its magicJack devices.

Another thing it does is make analysts look like perpetual underachievers. If analysts say the company posted a profit of $0.19 a share in its latest quarter, I'll argue that it held up better than that. History's on my side!

One of my best tricks to beating the market is finding stocks that perpetually land ahead of the prognosticators. Let's go over the past year of earnings reports.

 Quarter

EPS Estimate

EPS

Surprise

Q4 2012

$0.60

$0.95

58%

Q1 2013

$0.51

$1.17

129%

Q2 2013

$0.32

$0.49

53%

Q3 2013

$0.42

$0.48

14%

Source: Thomson Reuters.

Things can change, of course. Analysts are starting to catch up as the strength of the bottom-line beats have weakened in each of the past two quarters. This is a competitive market, and it bears pointing out that analysts see magicJack VocalTec earning less than half as much as it did a year earlier.

It's still hard to argue against the trend. Everything seems to be falling into place for another market-thumping quarter on the bottom line.

Three for the road
Well, there are three predictions right there. Let's see how I fare this week as I leave you with three more recommendations. It's no secret that investors tend to be impatient with the market, but the best investment strategy is to buy shares in solid businesses and keep them for the long term. In the special free report "3 Stocks That Will Help You Retire Rich," The Motley Fool shares investment ideas and strategies that could help you build wealth for years to come. Click here to grab your free copy today.


Read/Post Comments (4) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On March 09, 2014, at 6:34 PM, EvolvingEdge wrote:

    I agree that NVAX may post a wider loss than expected. But is this as bad as it appears? Having been following their website career "open positions", they appear to be gearing up for manufacturing of vacines that are in the later stages of the approval process. These products, especially the RSV vaccine, have no equal and would gain blockbuster status immediately upon approval. Is something going on that may justify these "unexpected" expenses? Several analysts and HHS-BARDA seem to think so. We will probably know more in April.

  • Report this Comment On March 11, 2014, at 12:11 AM, Mtrouty1 wrote:

    RICK; You really blew the call on NVAX,Huh? Beat estimates and+ revenue!

  • Report this Comment On March 13, 2014, at 2:21 PM, Brian0621 wrote:

    I am having a hard time understanding why AMBA is on such a slide. They beat estimates and after hours trading was up over $1 at one point. From there on it has tanked. MF has not come out with any statements on this highly publicized stock. Does anyone have some clues?

  • Report this Comment On March 14, 2014, at 12:59 PM, Brian0621 wrote:

    Rick?

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2869788, ~/Articles/ArticleHandler.aspx, 12/22/2014 7:05:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement